Alpha Sense BI

FEBRUARY 6, 2024

This research often includes assessing the financial performance, market potential, competitive landscape, regulatory environment and growth potential of target healthcare companies, drugs, medical technologies, treatments and more.

Research 98

Research Primary Research Due Diligence Competitive Positioning 98

Alpha Sense BI

MARCH 21, 2024

One AlphaSense customer has saved tens of thousands of dollars by using our AI-search technology to optimize their research at various pharmaceutical companies. Expert Networks are Primarily for Market Research Another misconception about expert networks is that they can only be used for market research.

Primary Research 59

Primary Research Due Diligence SWOT Pharmaceutical 59

Alpha Sense BI

FEBRUARY 3, 2023

Without an official system to check an organization’s commitment to its ESG policies, many shareholders and investors are doing their due diligence through fact-checking. timber, natural pharmaceuticals) and services (i.e., In fact, biodiversity attrition can also severely hinder a company’s bottom line.

Finance 98

Finance Due Diligence Banking Pharmaceutical 98

Alpha Sense BI

DECEMBER 12, 2023

These intangible factors indicate that even the most exhaustive due diligence processes can still leave gaps in the M&A research process. Comprehensive Due Diligence Thorough due diligence on a target company is undeniably the cornerstone of successful M&A.

Due Diligence 52

Due Diligence Primary Research Competitive Intelligence Market Intelligence 52

Alpha Sense BI

MAY 28, 2024

Below, we explore the factors constraining venture capital funding into the first half of the year, and the ways investors can leverage crucial market intelligence to gain a competitive advantage in the shifting landscape. The VC Funding Dryspell Venture capital investment fell to the lowest activity in nearly five years for Q1 2024.

Capital 69

Capital Startups Biotech Due Diligence 69

Alpha Sense BI

APRIL 12, 2024

Generally, expert calls provide investment researchers with the operator’s perspective, which is critical to understanding competitive moats and enhancing data-driven research with soft data. You think, ‘I have competitively a better methodology, a better framework, and you think the world will go on it.’ It’s one of those things.

Primary Research 52

Primary Research Advantage Advantage Research 52

Alpha Sense BI

DECEMBER 15, 2023

Massive Data Analysis It’s clear that the pharmaceutical industry is increasingly in need of handling and interpreting expansive datasets efficiently and accurately. Adapting to these changes positions biopharma brands advantageously in a competitive landscape, ensuring they remain relevant and visible.

Pharmaceutical 52

Pharmaceutical Algorithm Predictive Analytics Research 52